Breast growth induced by estrogen (and progesteron) administered f o r 0.5-4 yrs, was evaluated i n g i r l s aged 11-22 y r s belonging t o 4 c l i n i c a l e n t i t i e s . G r . A. Gonadal dysgenesis (GO), n=29. Primary ovarian f a i l u r e , high gonadotrophins (Gn), normal hypothalam-pituitary function (H-P-fl . I n GD the treatment l e d t o f u l l development o f secondary sex characteristics. I n IGnD, MPHD and 17 OHD breast development was incomplete. It i s concluded t h a t gonadotrophin plays a r o l e i n breast development but the mechanism remains t o be c l a r i f i e d . I t i s proposed t h a t i n IGnD o r MPHD a more physiologic approach t o therapy be designed, possibly including a1 so gonadotrophins. TSH630' 9,5+4,1 mE/1 o r 580+230% lncreose. None negative Test. Conclusions: The maximal TRH-induced TSH-secretion i s agedepended. I n c h i l d r e n beyond 2 years we f i n d h i g h e r l e v e l s . The o p t i m a l TRH-dosage i n c h i l d r e n and adolescents i s lug/kg i.v. There was none nonresponder. S t i m u l a t i o n w i t h o h i g h e r dosage g i v e s no more i n f o r m a t i o n , i f we want t o know,whether t h e p i t u i t a r y -t h y r o i d -a x i s i s i n t o c t , t h e TSH-secretion i s suppressad, o r absent.
